{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:33:53Z","timestamp":1792103633855,"version":"4.4.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000051","name":"NHGRI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jacadv.2026.102697","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:17:58Z","timestamp":1774466278000},"page":"102697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lp(a) Has Specific Effects on Coronary Artery Disease Independent of LDL-C"],"prefix":"10.1016","volume":"5","author":[{"given":"Moa P.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Koenigsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Y.","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Raffield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaotong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna F.","family":"Ballou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"John N.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8505-9268","authenticated-orcid":false,"given":"Thibaut","family":"Davy-Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helina","family":"Kassahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shia T.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Antonio G.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri L.","family":"Monda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari E.","family":"North","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Yarosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy L.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2026.102697_bib1","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.102697_bib2","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1194\/jlr.P091249","article-title":"Heritability of apolipoprotein (a) traits in two-generational African-American and Caucasian families","volume":"60","author":"Enkhmaa","year":"2019","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacadv.2026.102697_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2022-002060","article-title":"Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease","volume":"9","author":"Nissen","year":"2022","journal-title":"Open Heart"},{"key":"10.1016\/j.jacadv.2026.102697_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1194\/jlr.R071571","article-title":"Lipoprotein (a): a historical appraisal","volume":"58","author":"Kostner","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacadv.2026.102697_bib5","first-page":"287","article-title":"Is Lipoprotein(a) ready for prime-time use in the clinic?","volume":"36","author":"Ellis","year":"2018","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.jacadv.2026.102697_bib6","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.102697_bib7","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/cvr\/cvab100","article-title":"Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics","volume":"118","author":"Swerdlow","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacadv.2026.102697_bib8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.102697_bib9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jacc.2022.06.019","article-title":"Ancestry, Lipoprotein(a), and cardiovascular risk thresholds: JACC review topic of the week","volume":"80","author":"Tsimikas","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.102697_bib10","doi-asserted-by":"crossref","first-page":"11992","DOI":"10.1073\/pnas.94.22.11992","article-title":"Convergent evolution of apolipoprotein(a) in primates and hedgehog","volume":"94","author":"Lawn","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacadv.2026.102697_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.atherosclerosis.2022.04.016","article-title":"Lipoprotein (a) and diabetes mellitus","volume":"349","author":"Lamina","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacadv.2026.102697_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamacardio.2020.5398","article-title":"Clinical utility of Lipoprotein(a) and LPA genetic risk score in risk prediction of incident atherosclerotic cardiovascular disease","volume":"6","author":"Trinder","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2026.102697_bib13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jacl.2019.04.010","article-title":"Use of Lipoprotein(a) in clinical practice: a biomarker whose time has come. A scientific statement from the National Lipid Association","volume":"13","author":"Wilson","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacadv.2026.102697_bib14","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.102697_bib15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2337\/diab.40.6.787","article-title":"Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria","volume":"40","author":"Jenkins","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.jacadv.2026.102697_bib16","first-page":"133","article-title":"Elevated serum Lp(a) levels in the early and advanced stages of breast cancer","volume":"14","author":"Kokoglu","year":"1994","journal-title":"Cancer Biochem Biophys"},{"key":"10.1016\/j.jacadv.2026.102697_bib17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10157-013-0875-8","article-title":"Causes and consequences of Lipoprotein(a) abnormalities in kidney disease","volume":"18","author":"Kronenberg","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jacadv.2026.102697_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cca.2016.07.003","article-title":"Association between Lipoprotein(a) and nonalcoholic fatty liver disease among Korean adults","volume":"461","author":"Nam","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacadv.2026.102697_bib19","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/bioinformatics\/btq126","article-title":"PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations","volume":"26","author":"Denny","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jacadv.2026.102697_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003354","article-title":"Associations of genetically predicted Lp(a) (Lipoprotein [a]) levels with cardiovascular traits in individuals of European and African ancestry","volume":"14","author":"Satterfield","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacadv.2026.102697_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155347","article-title":"Circulating lipoprotein(a) levels and health outcomes: Phenome-wide Mendelian randomization and disease-trajectory analyses","volume":"137","author":"Larsson","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.jacadv.2026.102697_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/ATVBAHA.120.315291","article-title":"Lp(a) (Lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national Biobank","volume":"41","author":"Patel","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacadv.2026.102697_bib23","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/ATVBAHA.114.304785","article-title":"Race is a key variable in assigning Lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis","volume":"35","author":"Guan","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacadv.2026.102697_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1194\/jlr.R052258","article-title":"Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humans","volume":"57","author":"Graham","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacadv.2026.102697_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacadv.2026.102697_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jacadv.2026.102697_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/mpr.1608","article-title":"A tutorial on conducting genome-wide association studies: quality control and statistical analysis","volume":"27","author":"Marees","year":"2018","journal-title":"Int J Methods Psychiatr Res"},{"key":"10.1016\/j.jacadv.2026.102697_bib28","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1038\/s41596-020-0353-1","article-title":"Tutorial: a guide to performing polygenic risk score analyses","volume":"15","author":"Choi","year":"2020","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jacadv.2026.102697_bib29","series-title":"UK Biobank Biomarker Project: Companion Document to Accompany Serum Biomarker Data","author":"Fry","year":"2019"},{"key":"10.1016\/j.jacadv.2026.102697_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002382","article-title":"Ancestral diversity in Lipoprotein(a) studies helps address evidence gaps","volume":"10","author":"Lee","year":"2023","journal-title":"Open Heart"},{"key":"10.1016\/j.jacadv.2026.102697_bib31","doi-asserted-by":"crossref","DOI":"10.2196\/14325","article-title":"Mapping ICD-10 and ICD-10-CM codes to phecodes: workflow development and initial evaluation","volume":"7","author":"Wu","year":"2019","journal-title":"JMIR Med Inform"},{"key":"10.1016\/j.jacadv.2026.102697_bib32","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/bioinformatics\/btu197","article-title":"R PheWAS: data analysis and plotting tools for phenome-wide association studies in the R environment","volume":"30","author":"Carroll","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jacadv.2026.102697_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2004.02.013","article-title":"Accuracy of medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records","volume":"148","author":"Kiyota","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacadv.2026.102697_bib34","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.mlr.0000160417.39497.a9","article-title":"Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors","volume":"43","author":"Birman-Deych","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.jacadv.2026.102697_bib35","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1214\/aos\/1013699998","article-title":"The control of the false discovery rate in multiple testing under dependency","volume":"29","author":"Benjamini","year":"2001","journal-title":"Ann Statist"},{"key":"10.1016\/j.jacadv.2026.102697_bib36","first-page":"3","article-title":"Maximally selected rank statistics in R","volume":"2","author":"Hothorn","year":"2002","journal-title":"R News"},{"key":"10.1016\/j.jacadv.2026.102697_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2307\/2532740","article-title":"Maximally selected rank statistics","volume":"48","author":"Lausen","year":"1992","journal-title":"Biometrics"},{"key":"10.1016\/j.jacadv.2026.102697_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1010762","article-title":"Combining Mendelian randomization and network deconvolution for inference of causal networks with GWAS summary data","volume":"19","author":"Lin","year":"2023","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jacadv.2026.102697_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jacl.2022.10.004","article-title":"Lipoprotein(a) and inflammation- pathophysiological links and clinical implications for cardiovascular disease","volume":"17","author":"Simantiris","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacadv.2026.102697_bib40","article-title":"The MRC IEU OpenGWAS data infrastructure","author":"Elsworth","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jacadv.2026.102697_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/biom12010026","article-title":"Lipoprotein(a)-the crossroads of atherosclerosis, atherothrombosis and inflammation","volume":"12","author":"Ugovsek","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jacadv.2026.102697_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2022.04.015","article-title":"Lipoprotein(a) and cardiovascular and valvular diseases: a genetic epidemiological perspective","volume":"349","author":"Arsenault","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacadv.2026.102697_bib43","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2019.10.019","article-title":"Lipoprotein(a) concentration and risks of cardiovascular disease and diabetes","volume":"74","author":"Gudbjartsson","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.102697_bib44","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abg8289","article-title":"Protein-coding repeat polymorphisms strongly shape diverse human phenotypes","volume":"373","author":"Mukamel","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jacadv.2026.102697_bib45","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ng749","article-title":"Replication validity of genetic association studies","volume":"29","author":"Ioannidis","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacadv.2026.102697_bib46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13073-020-00771-0","article-title":"Investigation of a nonsense mutation located in the complex KIV-2 copy number variation region of apolipoprotein(a) in 10,910 individuals","volume":"12","author":"Di Maio","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.jacadv.2026.102697_bib47","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2337\/dc20-2842","article-title":"Relation of Lipoprotein(a) levels to incident type 2 diabetes and modification by alirocumab treatment","volume":"44","author":"Schwartz","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacadv.2026.102697_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/MOL.0000000000000735","article-title":"Editorial comment: when Mendelian randomization goes astray","volume":"32","author":"Hegele","year":"2021","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacadv.2026.102697_bib49","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","article-title":"HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials","volume":"385","author":"Swerdlow","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2026.102697_bib50","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2026.102697_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S2213-8587(16)30396-5","article-title":"PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study","volume":"5","author":"Schmidt","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacadv.2026.102697_bib52","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/1074248420924983","article-title":"Proprotein convertase Subtilisin\/Kexin type 9 inhibitors and ezetimibe on risk of new-onset diabetes: a systematic review and meta-analysis of large, double-blinded randomized controlled trials","volume":"25","author":"Chiu","year":"2020","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jacadv.2026.102697_bib53","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.2016.14568","article-title":"Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis","volume":"316","author":"Lotta","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2026.102697_bib54","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a040980","article-title":"Using mendelian randomization to improve the design of randomized trials","volume":"11","author":"Ference","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jacadv.2026.102697_bib55","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacadv.2026.102697_bib56","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1038\/s41467-022-34216-6","article-title":"Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure","volume":"13","author":"Levin","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacadv.2026.102697_bib57","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/CIRCULATIONAHA.106.623199","article-title":"Navigating the crossroads of coronary artery disease and heart failure","volume":"114","author":"Gheorghiade","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.102697_bib58","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0021-9150(00)00719-X","article-title":"Lipoprotein (a) and development of intermittent claudication and major cardiovascular events in men and women: the Edinburgh Artery Study","volume":"157","author":"Price","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacadv.2026.102697_bib59","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/ATVBAHA.118.311857","article-title":"Lipoprotein(a) and risk of ischemic stroke in the REGARDS study","volume":"39","author":"Arora","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacadv.2026.102697_bib60","first-page":"1129","article-title":"2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacadv.2026.102697_bib61","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/hmg\/8.11.2087","article-title":"Molecular basis of congenital lp(a) deficiency: a frequent apo(a) 'null' mutation in caucasians","volume":"8","author":"Ogorelkova","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacadv.2026.102697_bib62","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1194\/jlr.M094540","article-title":"Nonsynonymous SNPs in LPA homologous to plasminogen deficiency mutants represent novel null apo(a) alleles","volume":"61","author":"Morgan","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacadv.2026.102697_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104537","article-title":"The causal effects of lipid traits on kidney function in Africans: bidirectional and multivariable mendelian-randomization study","volume":"90","author":"Kintu","year":"2023","journal-title":"EBioMedicine"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26001158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26001158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:53:18Z","timestamp":1785797598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26001158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2772963X26001158"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102697","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lp(a) Has Specific Effects on Coronary Artery Disease Independent of LDL-C","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102697"}}